Cargando…

Posterior reversible encephalopathy syndrome (PRES) in an HIV-1 infected patient with disseminated varicella zoster virus: a case report

BACKGROUND: Posterior reversible encephalopathy syndrome (PRES) is an uncommon pathology characterized by the acute onset of headache, vomiting, altered consciousness, seizures and focal neurological deficits. It was initially described in the setting of hypertension, uremia and immunosuppression. I...

Descripción completa

Detalles Bibliográficos
Autores principales: Sasson, Sarah C, Oon, Aileen, Chagantri, Joga, Brew, Bruce J, Carr, Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3766018/
https://www.ncbi.nlm.nih.gov/pubmed/23981526
http://dx.doi.org/10.1186/1471-2334-13-396
_version_ 1782283445218574336
author Sasson, Sarah C
Oon, Aileen
Chagantri, Joga
Brew, Bruce J
Carr, Andrew
author_facet Sasson, Sarah C
Oon, Aileen
Chagantri, Joga
Brew, Bruce J
Carr, Andrew
author_sort Sasson, Sarah C
collection PubMed
description BACKGROUND: Posterior reversible encephalopathy syndrome (PRES) is an uncommon pathology characterized by the acute onset of headache, vomiting, altered consciousness, seizures and focal neurological deficits. It was initially described in the setting of hypertension, uremia and immunosuppression. In the last decade there have been emerging reports of PRES in patients with advanced human immunodeficiency virus (HIV)-infection in the presence of hypertension, dialysis, hypercalcaemia and two opportunistic infections: blastomycosis and tuberculosis (TB). CASE PRESENTATION: Here we present the case of a 54 year old male being treated for disseminated varicella zoster virus (VZV) and vasculopathy in the setting of HIV infection who acutely deteriorated to the point of requiring intubation. His clinicoradiological diagnosis was of PRES and he subsequently improved within 72 h with supportive management. Serial neuroimaging correlated with the clinical findings. The pathogenesis of PRES is poorly understood but is thought to stem from vasogenic oedema either as a result of loss of endothelial integrity and transudate of fluid across the blood–brain barrier, or secondary to vasospasm resulting in tissue oedema in the absence of infarction. How HIV infection impacts on this model is unclear. It is possible the HIV infection causes endothelial dysfunction and disruption of the blood–brain barrier that may be further exacerbated by infections in the central nervous system. CONCLUSION: The phenomenon of PRES in advanced HIV is an important clinical entity for both physicians and critical care doctors to recognize firstly given its potential mortality but also because of its favourable prognosis and reversibility with supportive care and treatment of underlying causes.
format Online
Article
Text
id pubmed-3766018
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-37660182013-09-08 Posterior reversible encephalopathy syndrome (PRES) in an HIV-1 infected patient with disseminated varicella zoster virus: a case report Sasson, Sarah C Oon, Aileen Chagantri, Joga Brew, Bruce J Carr, Andrew BMC Infect Dis Case Report BACKGROUND: Posterior reversible encephalopathy syndrome (PRES) is an uncommon pathology characterized by the acute onset of headache, vomiting, altered consciousness, seizures and focal neurological deficits. It was initially described in the setting of hypertension, uremia and immunosuppression. In the last decade there have been emerging reports of PRES in patients with advanced human immunodeficiency virus (HIV)-infection in the presence of hypertension, dialysis, hypercalcaemia and two opportunistic infections: blastomycosis and tuberculosis (TB). CASE PRESENTATION: Here we present the case of a 54 year old male being treated for disseminated varicella zoster virus (VZV) and vasculopathy in the setting of HIV infection who acutely deteriorated to the point of requiring intubation. His clinicoradiological diagnosis was of PRES and he subsequently improved within 72 h with supportive management. Serial neuroimaging correlated with the clinical findings. The pathogenesis of PRES is poorly understood but is thought to stem from vasogenic oedema either as a result of loss of endothelial integrity and transudate of fluid across the blood–brain barrier, or secondary to vasospasm resulting in tissue oedema in the absence of infarction. How HIV infection impacts on this model is unclear. It is possible the HIV infection causes endothelial dysfunction and disruption of the blood–brain barrier that may be further exacerbated by infections in the central nervous system. CONCLUSION: The phenomenon of PRES in advanced HIV is an important clinical entity for both physicians and critical care doctors to recognize firstly given its potential mortality but also because of its favourable prognosis and reversibility with supportive care and treatment of underlying causes. BioMed Central 2013-08-28 /pmc/articles/PMC3766018/ /pubmed/23981526 http://dx.doi.org/10.1186/1471-2334-13-396 Text en Copyright © 2013 Sasson et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Sasson, Sarah C
Oon, Aileen
Chagantri, Joga
Brew, Bruce J
Carr, Andrew
Posterior reversible encephalopathy syndrome (PRES) in an HIV-1 infected patient with disseminated varicella zoster virus: a case report
title Posterior reversible encephalopathy syndrome (PRES) in an HIV-1 infected patient with disseminated varicella zoster virus: a case report
title_full Posterior reversible encephalopathy syndrome (PRES) in an HIV-1 infected patient with disseminated varicella zoster virus: a case report
title_fullStr Posterior reversible encephalopathy syndrome (PRES) in an HIV-1 infected patient with disseminated varicella zoster virus: a case report
title_full_unstemmed Posterior reversible encephalopathy syndrome (PRES) in an HIV-1 infected patient with disseminated varicella zoster virus: a case report
title_short Posterior reversible encephalopathy syndrome (PRES) in an HIV-1 infected patient with disseminated varicella zoster virus: a case report
title_sort posterior reversible encephalopathy syndrome (pres) in an hiv-1 infected patient with disseminated varicella zoster virus: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3766018/
https://www.ncbi.nlm.nih.gov/pubmed/23981526
http://dx.doi.org/10.1186/1471-2334-13-396
work_keys_str_mv AT sassonsarahc posteriorreversibleencephalopathysyndromepresinanhiv1infectedpatientwithdisseminatedvaricellazostervirusacasereport
AT oonaileen posteriorreversibleencephalopathysyndromepresinanhiv1infectedpatientwithdisseminatedvaricellazostervirusacasereport
AT chagantrijoga posteriorreversibleencephalopathysyndromepresinanhiv1infectedpatientwithdisseminatedvaricellazostervirusacasereport
AT brewbrucej posteriorreversibleencephalopathysyndromepresinanhiv1infectedpatientwithdisseminatedvaricellazostervirusacasereport
AT carrandrew posteriorreversibleencephalopathysyndromepresinanhiv1infectedpatientwithdisseminatedvaricellazostervirusacasereport